EichorEICHOR
Study identifier: NCT05404230 Synced from ClinicalTrials.gov · August 08, 2026
● Study status: RecruitingOxaNeuro

Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities

Condition: Peripheral Neuropathy · Colorectal Cancer  ·  Sponsor: Vejle Hospital

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNoCheck eligibility criteria ↓
Where4 locations

Interested? Contact the study team ↓

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The purpose of this study is to examine the effect of supplementary polyunsaturated fatty acids on nerve damage in the body's extremitites of patients treated with oxaliplatin containing chemotherapy after surgery for colorectal cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Malene Nielsen, MD.  ·  +45 26823726  ·  Malene.Nielsen6@rsyd.dk

Karin Larsen  ·  + 45  ·  Karin.Larsen1@rsyd.dk

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Histopathologically verified adenocarcinoma of the colon or rectum and planned standard adjuvant treatment with capecitabine in combination with oxaliplatin. * ECOG performance status 0-2 (measurement of a patient's function in terms of self-care, daily activity and physical ability. * Written and orally informed informed consent Exclusion Criteria: * Inability to speak, read, and understand Danish. * Previous treatment with neurotoxic chemotherapy. * Neurological (including neuropathy) or psychiatric disorders, diabetes or other significant medical conditions. * Alcohol or drug abuse. * Sensory disturbances in the feet * Spinal stenosis. * Vascular disease (Fontaine grade II or more). * Known allergy to fish, fish oil or corn oil * Fertile patients not willing to use effective methods of contraception during treatment or abstinence. * Daily intake of oil supplements and not willing to stop during the trial period. * Lack of consent to skin biopsy

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (4)

Department of Oncology, AAUHAalborg, DenmarkRecruiting
Department of Oncology, AUHAarhus, DenmarkRecruiting
Department of OncologySønderborg, DenmarkRecruiting
Department of Oncology, Vejle HospitalVejle, DenmarkRecruiting

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

AalborgAarhusSønderborgVejle

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →